Accepted at 12:43 a.m. Feb, 09, 2025 by andrewmathias8
Author: gnigam
Related Note: 1485226947581
Rationale for change

Specifying that the carbidopa is only acting peripherally, as depicted in the picture below.

The original sentence makes it seems like it blocks dopamine production everywhere in the body (including brain).

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Neurology::26_Dementia::02_Parkinson_Disease #AK_Step2_v12::!Shelf::Neuro::no_dupes #AK_Step2_v12::#OME::02_Neurology::03_Tremor #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::04_Antipsychotics_&_Parkinsons::03_Parkinsonism_Drugs #AK_Step2_v12::Original_decks::Dorian::fam::ome::neuro::tremor #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Neurology::Parkinson_Drugs #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#UWorld::Step::265 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#FirstAid::09_Neuro::13_Movement_Disorders::02_Parkinson_Disease_and_Parkinsonis #AK_Step2_v12::#Resources_by_rotation::FM::ome::neuro::tremor #AK_Step1_v12::#AMBOSS::hPacek #AK_Step1_v12::#OME::Clinical::Neurology::Neurology::Tremor #AK_Step2_v12::#SketchyNeurology::04_Movement_&_Neurodegenerative_Disorders::02_Disorders_of_Basal_Ganglia::01_Parkinson_Disease #AK_Step1_v12::#Osmosis::16_Neuro::06_Pathology_-_Movement_&_balance_disorders::01_Parkinsons_disease #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman #AK_Step1_v12::#AMBOSS::JjasYk #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman::Parkinson_Disease_Drugs #AK_Step1_v12::#UWorld::COMLEX::23378 #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step2_v12::#Resources_by_rotation::Neuro::ome::tremor #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::07_Carbidopa/levodopa::*Carbidopa_Levodopa #AK_Step2_v12::Original_decks::Dorian::neuro::ome::tremor #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::14_Parkinson_Disease::Extra #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::10_Entacapone/Tolcapone #AK_Step2_v12::#B&B::10_Neuro::03_Movement_Disorders::01_Parkinson's_Disease::Extra #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::06_Parkinson_disease_therapy::*Carbidopa_Levodopa #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::11_Carbidopa/Levodopa,_COMT_Inhibitors_(Entacapone,_Tolcapone) #AK_Step1_v12::^Systems::Neuro::Pharmacology